All In Biotech

Investigational drug · Phase 3

VAD044 L-Tartrate gelatin

Also called: Engasertib, VAD044

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Hereditary Hemorrhagic Telangiectasia, Hereditary Hemorrhagic Telangiectasia (HHT).

Phase 3

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

1

Any phase or sponsor naming "VAD044 L-Tartrate gelatin"

First trial start

2022

Jul 18, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "VAD044 L-Tartrate gelatin", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Hereditary Hemorrhagic Telangiectasia
  • Hereditary Hemorrhagic Telangiectasia (HHT)

Approved drugs for the same conditions: Rare and genetic disease

Largest trials

Live from ClinicalTrials.gov: studies naming "VAD044 L-Tartrate gelatin" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 4 on PubMed

Also in development for Hereditary Hemorrhagic Telangiectasia

  • ALN-6400Phase 22 trials

    Alnylam Pharmaceuticals · Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB), Hereditary Hemorrhagic Telangiectasia

  • DIAG723Phase 21 trial

    Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.